Howard Fillit

, MD

Co-Founder and Chief Science Officer, Alzheimer’s Drug Discovery Foundation

Howard Fillit, MD, is a geriatrician, neuroscientist, and innovative philanthropy executive, who has led the Alzheimer’s Drug Discovery Foundation since its founding. Dr. Fillit has held faculty positions at The Rockefeller University, the SUNY-Stony Brook School of Medicine and the Cornell University School of Medicine. In 1987, he joined the Mount Sinai School of Medicine, where he is a clinical professor of geriatric medicine and palliative care, medicine and neuroscience. Dr. Fillit also maintains a limited private practice in consultative geriatric medicine with a focus on Alzheimer's disease and related dementias.

He has authored or co-authored more than 350publications and is the senior editor of Brocklehurst's Textbook of Geriatric Medicine and Gerontology. Dr. Fillit is the recipient of many awards and honors including the Rita Hayworth Award from the Alzheimer's Association. He is a fellow of the American Geriatrics Society, the American College of Physicians, the Gerontological Society of America and the New York Academy of Medicine. Dr. Fillit earned his Bachelor of Arts in neurobiology cum laude from Cornell University and his medical degree from the SUNY-Upstate Medical University.

In the past three years, Dr. Fillit has consulted for Alector, LifeWorx, Mediflix, Samus Therapeutics, Otsuka Pharmaceuticals, and Pinteon Therapeutics and has been an unpaid consultant for Lilly.

Read more

This Speaker's Sessions

PANEL
Wednesday Oct. 18
-
2:30-3:15 PM
Watch Replay
Now Live!

One Size Fits One: Precision Medicine and Alzheimer’s Prevention

Proactive, precision, whole health medicine is the next frontier in healthcare. What does this mean for Alzheimer’s? Learn how advances in technology, lifestyle medicine, and preventive therapeutics help not only prevent chronic conditions like heart disease and diabetes but also maintain cognition into older years. It is never too early to talk about brain health. Key Question: How are the latest approaches and cutting-edge modalities giving health professionals an edge against Alzheimer’s?

View SessionWatch Replay
Town Hall
Thursday Oct. 14
-
1:30-2:15 pm
Watch Replay
Now Live!

Disrupting Brain Health Through Technology: The Hope, the Challenge, the Future

Technology and data hold great promise for ending Alzheimer’s—from tailored prevention to detection, diagnosis, and precision treatments. Of course, these technologies will be meaningless to historically underserved or marginalized groups if they are developed without diverse populations in mind.  This session will explore how technology and data are deepening our understanding of Alzheimer’s disease and what needs to be done to ensure it is inclusive and accessible to all.   

View SessionWatch Replay